Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-10Clinical Trial Results: Efficacy of Caregiver Training Program in Enhancing Caregiver and Patient Outcomes [NA]
Clinical trial results evaluating a caregiver training program to improve outcomes for patients with Alzheimer disease and dementia, with ca…
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: Metformin in Alzheimer's Dementia Prevention [Phase 2, Phase 3]
A clinical trial updating on metformin for prevention of Alzheimer’s dementia in individuals with mild cognitive impairment, spanning Phase …
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Update: AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid [Phase 3]
Phase 3 trial update for lecanemab in preclinical Alzheimer's disease with elevated amyloid, including early preclinical stages.
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5) [Phase 3]
Phase 3 trial update for donanemab (LY3002813) in early symptomatic Alzheimer's disease (TRAILBLAZER-ALZ 5) is active/not recruiting.
-
EMA approval · 2026-04-28EMA Authorised: Neuraceq (florbetaben (18F)) — Lantheus Germany GmbH
EMA has authorised Neuraceq (florbetaben 18F) for radionuclide imaging related to Alzheimer disease.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Use of Socially Assistive Robots for Long Term Care Older Adults With Cognitive Impairment and Apathy [Phase 1, Phase 2]
A completed clinical trial investigating socially assistive robots for long-term care in older adults with cognitive impairment and apathy, …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Efficacy and Safety of Temporal Interference Stimulation on Cognitive Function in Patients With Early-Stage Alzheimer's Disease [NA]
A clinical trial is evaluating the efficacy and safety of temporal interference stimulation for cognitive function in patients with early-st…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease [Phase 1]
A Phase 1 clinical trial is evaluating PET imaging of cyclooxygenases in neurodegenerative brain diseases, with recruitment ongoing.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental Disorders
A prospective observational study examining how sociodemographic factors, blood-based biomarkers, and psychiatric symptoms relate across sev…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Detecting Beta-amyloid in the Retina [NA]
A clinical trial update from the Center for Eye Research Australia on detecting retinal beta-amyloid in dementia and Alzheimer's disease has…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) [Phase 1]
Phase 1 clinical trial update evaluating a PET imaging agent targeting phosphodiesterase-4 (PDE4) in volunteers including individuals with A…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease [Phase 1]
A Phase 1 clinical trial evaluating ALN-5288 in patients with Alzheimer's disease is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Effect of Scene-Based Training on Cognitive Function in Patients With Alzheimer's Disease [NA]
A completed clinical trial evaluated whether scene-based training improves cognitive function in individuals with Alzheimer's disease, mild …
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease [NA]
A completed clinical trial from the University of British Columbia evaluates a medium-chain triglyceride intervention in Alzheimer's disease…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: The Brain&Senses Study
The Brain&Senses Study is an active but not recruiting clinical trial sponsored by the University of Campania Luigi Vanvitelli, investigatin…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease [Phase 4]
This clinical trial update describes a Phase 4 study of daridorexant for insomnia in patients with mild cognitive impairment and Alzheimer's…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD [Phase 3]
A Phase 3 double-blind study is assessing the safety and efficacy of Buntanetap in participants with early Alzheimer's disease. The trial is…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Use of Socially Assistive Robots for Long Term Care Older Adults With Cognitive Impairment and Apathy [Phase 1, Phase 2]
Clinical trial update on the use of socially assistive robots to support long-term care in older adults with Alzheimer disease, conducted ac…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia [NA]
This clinical trial evaluates the efficacy and safety of ATNC-MDD V1, a transcranial magnetic stimulation (TMS) with cognitive training, for…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease [Phase 2, Phase 3]
Clinical trial update indicating that Actinogen Medical's Xanamem (10 mg) is being studied for dementia related to Alzheimer's disease in Ph…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2) [Phase 3]
Phase 3 clinical trial ADAGIO-2 is evaluating the safety and efficacy of KarXT plus KarX-EC for agitation in Alzheimer's disease and is curr…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Choline Effects - Pre-symptomatic AD [Phase 1]
A Phase 1 study evaluating the effects of choline in people who are pre-symptomatic for Alzheimer's disease has completed.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Retinal Hyperspectral Imaging in Neurodegenerative Diseases [NA]
A clinical trial is investigating retinal hyperspectral imaging for neurodegenerative diseases and dementia, currently recruiting participan…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1) [Phase 3]
A Phase 3 clinical trial (ADEPT-1, NCT05511363) evaluating KarXT for psychosis associated with Alzheimer's disease is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1) [Phase 3]
A Phase 3 clinical trial is evaluating the safety and efficacy of KarXT plus KarX-EC for agitation in Alzheimer's disease, and the study is …